Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Elite Health Systems (EHSI) Free Cash Flow (2016 - 2025)

Elite Health Systems' Free Cash Flow history spans 16 years, with the latest figure at -$1.5 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$1.5 million for Q4 2025, down 186.34% from a year ago — trailing twelve months through Dec 2025 was -$3.9 million (down 160.66% YoY), and the annual figure for FY2025 was -$3.9 million, down 160.66%.
  • Free Cash Flow for Q4 2025 was -$1.5 million at Elite Health Systems, down from -$1.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $421000.0 in Q2 2021 to a low of -$1.5 million in Q4 2025.
  • The 5-year median for Free Cash Flow is -$328000.0 (2022), against an average of -$379700.0.
  • The sharpest move saw Free Cash Flow skyrocketed 175.64% in 2023, then crashed 1347.22% in 2025.
  • Year by year, Free Cash Flow stood at -$268000.0 in 2021, then decreased by 1.49% to -$272000.0 in 2022, then decreased by 17.65% to -$320000.0 in 2023, then tumbled by 64.69% to -$527000.0 in 2024, then crashed by 186.34% to -$1.5 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$1.5 million, -$1.0 million, and -$575000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.